1Pharm. D (Doctor of Pharmacy), 2Pharm. D (Doctor of Pharmacy), 3Pharm. D (Doctor of Pharmacy), 3Pharm. D (Doctor of Pharmacy), 4Pharm. D (Doctor of Pharmacy), 5Diabetes Educator, Assistant Professor, Department of Clinical Pharmacy, Vaageswari College of Pharmacy, Karimnagar, Hanamkonda, Telangana 506001, India. 6 Consultant Physician and Diabetologist, Sri Bhadrakali Diabetes Care Centre, Warangal, Telangana 506002, India.
Choose an option to locate / access this Article:
90 days Access
Check if you have access
through your login credentials.
PDF
Objective: The main aim of the study is to inspect specific state of the disease – Diabetes Mellitus by screening Glycated Hemoglobin, Fasting plasma glucose and spectrum of complications. Study Design: An Observational study carried out for 6 months (October 2018-March 2019) in 688 diabetic patients. Results: Glycated hemoglobin is ≤ 6.9% in 14% of total patients and 86% of the patients are having ≥ 7%, 15% of total 688 diabetic patients are maintaining fasting plasma glucose levels ≤ 108 mg/dl. Conclusion: An abnormal maintainance of glycemic levels is responsible for the development of diabetic complications. Diabetic educators and clinical pharmacist interventions can reduce glycemic levels along with the physician aided pharmacological treatment. Proper central and local management interventions and combined efforts from all the stakeholders of the the general public is a requisite to trim down the disease burden that diabetes creates in India.
Keywords : Diabetes mellitus; Glycemic control, Glycated hemoglobin; Fasting plasma glucose; Spectrum of complications; Diabetes care and management
Corresponding Author : Nikhil Kumar Vanjari, Diabetes Educator, Assistant Professor, Department of Clinical Pharmacy, Vaageswari College of Pharmacy, Karimnagar, Hanamkonda, Telangana 506001, India. nikhil71311@gmail.com